ScholarIQanswers from OpenAlex & ORCID
Lillian L. Siu
ResearcherPublications, citations & collaboration network
Lillian L. Siu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lillian L. Siu have?
ScholarIQindexed works
Lillian L. Siu has 1,301 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lillian L. Siu have?
ScholarIQcitation count
Lillian L. Siu has 41,779 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lillian L. Siu?
ScholarIQh-index
Lillian L. Siu has an h-index of 102 in OpenAlex.
What is the i10-index of Lillian L. Siu?
ScholarIQi10-index
Lillian L. Siu has an i10-index of 419 in OpenAlex.
What is the ORCID of Lillian L. Siu?
ScholarIQorcid
The ORCID for Lillian L. Siu is on the source record.
What is the OpenAlex record for Lillian L. Siu?
ScholarIQopenalex
The OpenAlex for Lillian L. Siu is on the source record.
What are the most-cited papers on Lillian L. Siu?
ScholarIQmost cited works
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice André, Mónica Arnedos, Alexander S. Baras, José Baselga, Philippe L. Bédard, Michael F. Berger, Mariska Bierkens, Fabien Calvo, Ethan Cerami, Debyani Chakravarty, Kristen K. Dang, Nancy E. Davidson, Catherine Del Vecchio Fitz, Semih Doğan, Raymond N. DuBois, Matthew D. Ducar, P. Andrew Futreal, Jianjiong Gao, Francisco Moacir Pinheiro Garcia, Stuart M. Gardos, Christopher D. Gocke, Benjamin Groß, Justin Guinney, Zachary Heins, Stephanie Hintzen, Hugo M. Horlings, Jan Hudeček, David M. Hyman, Suzanne Kamel‐Reid, Cyriac Kandoth, Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
Ignacio Durán, Jeremy Kortmansky, Deepti Singh, Hal W. Hirte, Walter Kocha, Glenwood D. Goss, Lyly Le, Amit M. Oza, Trudey Nicklee, Jcm Ho, Diana C. Birle, Gregory R. Pond, D Arboine, Janet Dancey, Sarit Aviel‐Ronen, M-S Tsao, David W. Hedley, Lillian L. Siu
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin, Jean‐Charles Soria, Anastasios Stathis, Jean‐Pierre Delord, Solange Peters, Ahmad Awada, Philippe Aftimos, Mohamed Békradda, Keyvan Rezaï, Zhen Zeng, Azher Hussain, Susan Perez, Lillian L. Siu, Christophe Massard
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands
Mark Agulnik, Ezra E.W. Cohen, Roger B. Cohen, Eric X. Chen, Everett E. Vokes, Sebastién J. Hotte, Eric Winquist, Scott A. Laurie, D. Neil Hayes, Janet Dancey, Shirley Brown, Gregory R. Pond, Ian Lorimer, Manijeh Daneshmand, Jcm Ho, Ming‐Sound Tsao, Lillian L. Siu